Tuesday, November 24, 2009, 5:39pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Kensey Nash Corp. (KNSY)

At 16:00 EST: 24.14 USD  Up 0.43 (1.81%)  
MORE ON KNSY
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Kensey Nash Corporation (NasdaqNM:KNSY) Delayed quote dataEdit
After Hours: 24.00 Down 0.14 (0.56%) as of 4:08pm EST on 11/24/09
Last Trade: 24.14 USD
Trade Time: 4:00PM EST
Change: Up 0.43 (1.81%)
Prev Close: 23.71
Open: 23.64
Bid: 23.20 x 100
Ask: 24.81 x 600
1y Target Est: 32.00
Day's Range: 23.47 - 24.35
52wk Range: 15.11 - 29.73
Volume: 63,261
Avg Vol (3m): 68,047.7
Market Cap: 267.76M
P/E (ttm): 14.32
EPS (ttm): 1.69
Div & Yield: N/A (N/A%)
Kensey Nash Corp. (KNSY)
1d  5d  3m  6m  1y  2y  5y  max 
 Add KNSY to Portfolio   Download Data

HEADLINES
KENSEY NASH CORP Financials
EDGAR Online Financials (Fri, Nov 13)
Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product Company's First ECM Approval
PRNewswire (Wed, Nov 11)
KENSEY NASH CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
KENSEY NASH CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Nov 4)
Coverage initiated on Kensey Nash by Barrington Research
Briefing.com (Tue, Oct 27)
Earnings roundup: Amazon.com, McDonald's
AP (Thu, Oct 22)
Kensey Nash 1Q profit falls on flat product sales
AP (Thu, Oct 22)
Kensey Nash Corporation Earnings Call scheduled for 9:00 am ET today
CCBN (Thu, Oct 22)
KENSEY NASH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Oct 22)
Kensey Nash Reports First Quarter Fiscal Year 2010 Financial Results
PRNewswire (Thu, Oct 22)
More Headlines for KNSY...

ANALYST
EPS Est (next year) (Jun-10) : 1.76
EPS Est (in 2 years) (Jun-11) : 1.91
Avg Rec (current)*: 2.0
PEG Ratio: 0.75
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Kensey Nash Corporation, a medical device company, develops products and technologies in the fields of resorbable biomaterials and endovascular devices used in various medical procedures.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices